Chronic hepatitis C: a systemic disease

Minerva Med. 2021 Apr;112(2):159-161. doi: 10.23736/S0026-4806.21.07410-3. Epub 2021 Feb 8.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cryoglobulinemia / complications
  • Cryoglobulinemia / drug therapy
  • Cryoglobulinemia / immunology
  • Cryoglobulinemia / virology
  • Hepacivirus* / pathogenicity
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / immunology
  • Hepatitis C, Chronic / virology
  • Humans
  • Immunologic Factors / therapeutic use
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / immunology
  • Lymphoproliferative Disorders / immunology
  • Nephritis / classification
  • Nephritis / drug therapy
  • Rituximab / therapeutic use
  • Vasculitis / drug therapy

Substances

  • Antiviral Agents
  • Immunologic Factors
  • Rituximab